Lotrel News
Novartis Fourth-Quarter Net Drops on Job Cut Costs (Update4) - Bloomberg
It's also facing generic competition to a number of drugs including the Lotrel heart pill. ``The share buyback is nice from an investor's point of view but ...
Teva, generic firms seen doing more risky launches - Guardian Unlimited
Israel-based Teva took a similar calculated risk last year with its generics of the big-selling blood-pressure drug Lotrel and the herpes treatment Famvir, ...
Novartis achieves record results in - Ad-Hoc-News (Pressemitteilung)
all 8 news articles
Novartis Achieves Record Results in 2007 Underscoring Benefits of ... - PharmaLive.com (press release)
US net sales fell 8% after the loss of Lotrel, Lamisil, Trileptal and Famvir to generics and the suspension of Zelnorm. However, worldwide net sales rose ...
Retailers, banks pace European share gains - MarketWatch
US pharmaceutical sales fell 21% in the quarter due to generic competition for four products - Lotrel, Lamisil, Trileptal and Famvir - and the suspension of ...
Novartis posts 45-percent drop in 4Q net profit, hit by ... - PR-Inside.com (Pressemitteilung)
The loss of its bowel drug Zelnorm and generic competition for some of its best-selling products, including hypertension drug Lotrel, squeezed results.
Pharma Blog Watch - FDA news (subscription)
... report of its fourth-quarter profit, which missed analyst estimates because of generic competition to its heart medicine Lotrel and antifungal Lamisil. ...
Teva to Explore Strategic Alternatives for its Animal Health Business - FOXNews
... Neurontin(R), Lotrel(R) Famvir(R) and Protonix(R), Teva`s ability to successfully develop and commercialize additional pharmaceutical products, ...
BRIT.ENG.GP ORD 10P NEWS - Ad-Hoc-News (Pressemitteilung)
... Neurontin®, Lotrel® Famvir® and Protonix®, Teva`s ability to successfully develop and commercialize additional pharmaceutical products, the introduction ...
Novartis says Q4, H1 to show strong negative - Hemscott
... to show a strong negative impact from US pharma sales, citing the loss of Zelnorm, and generic competition for Lamisil, Lotrel, Famvir and Trileptal. ...
Lotrel RSS Feed